Selenium a bust in lung cancerSupplement fails to prevent secondary tumour development Sponge-derived drug extends breast CA survivalEribulin among ‘handful’ of effective agents for metastatic disease Targeted lung cancer drug wows meeting Promising early trial results for crizotinib highlighted in plenary session Tool aids ovarian CA screening Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Radiation-hormone therapy combo best for high-risk prostate cancer Sponge-derived drug extends breast cancer survival Breast density decrease linked with lower cancer risk Targeted therapy battles late-stage lung cancer Researchers tailor treatment to tumour’s molecular signature First Previous 63 64 65 66 67 Next Last
